EGFR and lung carcinoma: Of note, two of the three confirmed peptides (H9R9 and K9R7) were derived from the well-described shared EGFR-L858R mutation harbored by ∼20% of Asian lung cancer patients, and less frequently (∼5%) by non-Asian patients.31